U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07805512) titled 'A Study to Evaluate the Effectiveness and Safety of Restylane Shaype in the Improvement of Jawline Definition' on Sept. 01.
Brief Summary: This is a randomized, evaluator-blinded, parallel group, no-treatment controlled, multicenter study to evaluate effectiveness and the safety of Restylane Shaype for improvement of jawline definition in China. Subjects of Chinese origin, age 18 years, who are eligible for treatment to improve jawline definition. Study sites is approximately 6.
A total of approximately 162 subjects will be randomized (2:1) to either treatment with Restylane Shaype Treatment Group (approximately 108subjects) or no-...